槲皮素对人正常与癌细胞辐射适应性调控的差异
本研究在MCF10A正常乳腺上皮细胞与MCF7乳腺癌细胞中比较低剂量放疗(0.1 Gy)、槲皮素及高剂量辐射对细胞活力、克隆存活、氧化应激和DNA损伤反应的影响。结果显示槲皮素增强正常细胞的辐射适应性(涉及NQO1、NRF2与ROS),而在癌细胞中不诱导适应并可能提高放射敏感性。提示槲皮素或可作为放疗调节剂以扩大治疗窗。
要点
- 槲皮素增强MCF10A正常细胞的辐射适应性并提高细胞活力与存活分数。
- 机制涉及NQO1/NRF2抗氧化通路激活与24 h ROS降低。
- MCF7癌细胞无辐射适应反应,槲皮素反而增加其放射敏感性。
核心结论
- 槲皮素通过激活抗氧化通路并减少DNA损伤选择性增强正常细胞的辐射适应性,同时在癌细胞中保持或放大放射敏感性。
- 作者认为槲皮素可能作为具有良好安全性的潜在放疗调节剂,用于增大放疗治疗窗。
研究设计与样本
- 细胞实验比较人正常乳腺上皮MCF10A与乳腺癌MCF7细胞在低剂量放疗(0.1 Gy)、槲皮素及高剂量辐射处理后的反应。
- 评估指标包括细胞活力、克隆存活、氧化应激与DNA损伤反应,并用RT-qPCR、Western blotting和免疫荧光检测NQO1与NRF2表达,以γ-H2AX焦点和p-ATM水平评价DNA损伤。
主要发现
- 在MCF10A细胞中,低剂量放疗预处理增强其对后续辐射的抵抗,槲皮素进一步增强该效应:细胞活力升高(p = 0.007),10%存活分数下存活分数增强比=0.85。
- MCF10A中槲皮素在4 h增强NQO1 mRNA(p < 0.01)与蛋白(p < 0.01)表达,24 h对NQO1 mRNA(p = 0.890)与蛋白(p = 0.453)影响有限,并降低24 h ROS水平(p = 0.021)。
- 槲皮素促进MCF10A中NRF2去定位(p = 0.005)。
- MCF7细胞未见辐射适应反应,槲皮素反而增加放射敏感性(10%存活分数下存活分数增强比=1.12),并维持ROS水平与DNA损伤。
临床怎么用
- 结果提示槲皮素可能作为放疗调节剂,在保护正常组织的同时不削弱甚至增强对乳腺癌细胞的杀伤,但尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Radiotherapy is a primary treatment for many cancers, but its efficacy is often limited by collateral damage to healthy tissues. Radioadaptation, a phenomenon where low-dose radiotherapy (LDRT) enhances a cell's ability to withstand subsequent high-dose radiation, occurs in normal cells but is generally absent in cancer cells. Quercetin, a natural flavonoid with antioxidant and anticancer properties, has been proposed as a potential radiomodulator. This study aimed to investigate whether quercetin could differentially regulate the radioadaptive response in human normal breast epithelial versus breast cancer cells. METHODS: Cell viability, clonogenic survival, oxidative stress, and DNA damage responses were assessed in MCF10A and MCF7 cells following treatment with LDRT (0.1 Gy), quercetin, and high-dose radiation. NQO1 and NRF2 expression levels were measured using RT-qPCR, Western blotting, and immunofluorescence. DNA damage was evaluated by γ-H2AX foci and p-ATM levels. RESULTS: In MCF10A cells, LDRT pre-treatment enhanced resistance to subsequent radiation, which was further potentiated by quercetin, as shown by increased cell viability (p = 0.007), increased surviving fraction (enhancement ratio = 0.85, at 10 % surviving fraction), enhanced adaptation at 4 h on NQO1 mRNA (p < 0.01) and protein expression (p < 0.01), with a modest effect at 24 h on NQO1 mRNA (p = 0.890) and protein (p = 0.453) and reduced ROS level at 24 h (p = 0.021). Quercetin promoted NRF2 delocalization (p = 0.005). In contrast, MCF7 cells showed no radioadaptive response, and quercetin even increased radiosensitivity (enhancement ratio of surviving fraction = 1.12, at 10 surviving fraction) by maintaining ROS levels and DNA damage. CONCLUSION: Quercetin selectively enhances radioadaptation in normal cells by activating antioxidant pathways and reducing DNA damage, while preserving or amplifying radiosensitivity in cancer cells. These findings support quercetin may serve as a potential radiomodulating agent with favorable safety for increasing the therapeutic window of radiotherapy.
引用
- Li C, Li X, Biemans R, et al. Differential regulation of radioadaptation by quercetin between human normal and cancer cells. Clin Transl Radiat Oncol. 2025. PMID: 41531942. doi:10.1016/j.ctro.2025.101099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。